中东和非洲生物制药管市场预测至 2028 年 - COVID-19 影响和按类型（塑料、金属和硅胶）和应用（制药、医疗器械、研发等）进行的区域分析
No. of Pages: 115 | Report Code: TIPRE00024060 | Category: Life Sciences
No. of Pages: 115 | Report Code: TIPRE00024060 | Category: Life Sciences
中东和非洲生物制药管材市场预计将从2021年的13634万美元增至2028年的22670万美元；预计 2021 年至 2028 年复合年增长率为 7.5%。
市场的增长归因于一些关键驱动因素，例如世界老年人口增加、人口老龄化和人口老龄化等。对微创手术的需求。然而，政府对生物制药应用的严格监管框架预计将限制预测期内生物制药管市场的增长。
受欢迎程度近年来，由于微创手术具有切口小、患者恢复快、给患者带来的不适少等优点，因此越来越多的人接受微创手术。关节炎、癌症和心血管疾病的患病率不断上升，所有这些疾病都需要广泛的手术治疗，这增加了对微创手术的需求。因此，对导管和生物制药管材等组件的需求巨大。此外，生物制药管道系统价格合理，有助于节省时间。例如，使用导管进行心导管插入术和尿导管插入术可显着缩短医疗或外科手术所需的时间。因此，对微创医疗手术的需求不断增长以及对提高这些手术效率的关注在推动生物制药管材的需求方面发挥着重要作用。此外，越来越多地使用铂固化硅胶作为生物制药管材的首选材料，与传统的过氧化物固化管材相比具有多种优势。例如，2020 年 1 月，沃森马洛流体技术集团 (WMFTG) 推出了 BioPure 硅胶传输管，为各种生物工艺流体传输应用提供安全、可靠且经济高效的解决方案。因此，在预测期内，铂固化硅胶管作为首选材料的推出和使用可能会成为生物制药市场的一个重要趋势。因此，市场参与者有巨大的机会以优质且具有成本效益的产品进入市场。
COVID-19 大流行已成为中东地区最重大的挑战。对于伊拉克、苏丹、以色列和也门等该地区脆弱且饱受冲突蹂躏的国家来说，这一挑战尤其令人恐惧，因为这将导致全球贸易中断导致进口减少，从而加剧医疗用品和其他商品的短缺，导致价格大幅上涨。然而，由于该地区对包含管材的医疗设备的需求，本次疫情中的生物制药管材市场正在不断增长。
中东和非洲生物制药管材市场细分
按类型
按应用
按国家/地区
公司简介
Strategic insights for Middle East and Africa Biopharmaceutical Tubing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 136.34 Million |
| Market Size by 2028 | US$ 226.70 Million |
| Global CAGR (2021 - 2028) | 7.5% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East and Africa Biopharmaceutical Tubing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Biopharmaceutical Tubing Market is valued at US$ 136.34 Million in 2021, it is projected to reach US$ 226.70 Million by 2028.
As per our report Middle East and Africa Biopharmaceutical Tubing Market, the market size is valued at US$ 136.34 Million in 2021, projecting it to reach US$ 226.70 Million by 2028. This translates to a CAGR of approximately 7.5% during the forecast period.
The Middle East and Africa Biopharmaceutical Tubing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Biopharmaceutical Tubing Market report:
The Middle East and Africa Biopharmaceutical Tubing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Biopharmaceutical Tubing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Biopharmaceutical Tubing Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Biopharmaceutical Tubing Market
